BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36626416)

  • 1. Long-term prognosis after endoscopic resection of T1a-MM/T1b-SM1 esophageal squamous cell carcinoma.
    Ohki D; Tsuji Y; Shinozaki T; Sakaguchi Y; Mizutani H; Nagao S; Miura Y; Fukagawa K; Tamura N; Yakabi S; Yamamichi N; Fujishiro M
    Medicine (Baltimore); 2022 Dec; 101(49):e32115. PubMed ID: 36626416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment.
    Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J
    Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of metastatic recurrence after endoscopic resection for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa: a multicenter retrospective study.
    Hatta W; Koike T; Takahashi S; Shimada T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Hirasawa D; Ohira T; Nakamura J; Matsumoto T; Nakamura T; Nakaya N; Iijima K; Fukuda S; Masamune A;
    J Gastroenterol; 2021 Jul; 56(7):620-632. PubMed ID: 33881632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T1 squamous cell carcinoma of the esophagus: long-term outcomes and prognostic factors after esophagectomy.
    Tanaka T; Matono S; Mori N; Shirouzu K; Fujita H
    Ann Surg Oncol; 2014 Mar; 21(3):932-8. PubMed ID: 24232603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.
    Minashi K; Nihei K; Mizusawa J; Takizawa K; Yano T; Ezoe Y; Tsuchida T; Ono H; Iizuka T; Hanaoka N; Oda I; Morita Y; Tajika M; Fujiwara J; Yamamoto Y; Katada C; Hori S; Doyama H; Oyama T; Nebiki H; Amagai K; Kubota Y; Nishimura K; Kobayashi N; Suzuki T; Hirasawa K; Takeuchi T; Fukuda H; Muto M
    Gastroenterology; 2019 Aug; 157(2):382-390.e3. PubMed ID: 31014996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic invasion is a prognostic factor of pathological N0 esophageal squamous cell carcinoma.
    Toriumi T; Yagi K; Ri M; Yajima S; Okumura Y; Aikou S; Yamashita H; Nomura S; Seto Y
    Dis Esophagus; 2022 Jul; 35(7):. PubMed ID: 34937084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of endoscopic resection of preoperatively diagnosed non-circumferential T1a-muscularis mucosae or T1b-submucosa 1 esophageal squamous cell carcinoma.
    Namikawa K; Yoshio T; Yoshimizu S; Ishiyama A; Tsuchida T; Tokai Y; Horiuchi Y; Hirasawa T; Fujisaki J
    Sci Rep; 2021 Mar; 11(1):6554. PubMed ID: 33753766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
    Takahashi S; Hatta W; Watanabe K; Koike T; Shimada T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Hirasawa D; Ohira T; Nakamura J; Nakamura T; Nakaya N; Matsumoto T; Fukuda S; Masamune A; Iijima K
    Dig Dis Sci; 2023 May; 68(5):2050-2060. PubMed ID: 36445654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma.
    Kadota T; Sato D; Inaba A; Nishihara K; Takashima K; Nakajo K; Yukami H; Mishima S; Sawada K; Kotani D; Fujiwara H; Nakamura M; Hojo H; Yoda Y; Kojima T; Fujita T; Yano T
    Esophagus; 2022 Jan; 19(1):153-162. PubMed ID: 34420139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best additional management after non-curative endoscopic resection of esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Flor de Lima M; Castro B; Rodríguez-Carrasco M; Libânio D; Pimentel-Nunes P; Sousa O; Dinis-Ribeiro M
    Scand J Gastroenterol; 2022 May; 57(5):525-533. PubMed ID: 34986068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
    Tsou YK; Lee CH; Le PH; Chen BH
    Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma.
    Liu L; Lin H; Shen G; Liu Y; Qin X; Yuan Y; Wang B; Xue L
    BMC Cancer; 2023 Apr; 23(1):370. PubMed ID: 37087442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
    Sgourakis G; Gockel I; Lang H
    World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curative Management After Endoscopic Resection for Esophageal Squamous Cell Carcinoma Invading Muscularis Mucosa or Shallow Submucosal Layer-Multicenter Real-World Survey in Japan.
    Katada C; Yokoyama T; Hirasawa D; Iizuka T; Kikuchi D; Yano T; Hombu T; Yoshio T; Yoshimizu S; Ono H; Yabuuchi Y; Terai S; Hashimoto S; Takahashi K; Tanaka S; Urabe Y; Arima M; Tanabe S; Wada T; Furue Y; Oyama T; Takahashi A; Sakamoto Y; Muto M
    Am J Gastroenterol; 2023 Jul; 118(7):1175-1183. PubMed ID: 36624037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes of Follow-Up Observation After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa Without Lymphovascular Involvement.
    Iwai N; Dohi O; Yamada S; Ishida T; Fukui A; Horie R; Yasuda T; Yamada N; Horii Y; Majima A; Zen K; Yagi N; Naito Y; Itoh Y
    Dig Dis Sci; 2023 Sep; 68(9):3679-3687. PubMed ID: 37470897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study.
    Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H
    Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of recurrence and prognostic factors in patients with pT1-3 N0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience.
    Lin G; Liu H; Li J
    J Cardiothorac Surg; 2019 Mar; 14(1):58. PubMed ID: 30866983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphovascular Invasion as the Major Prognostic Factor in Node-Negative Esophageal Cancer After Primary Esophagectomy.
    Hsu CP; Chuang CY; Hsu PK; Chien LI; Lin CH; Yeh YC; Hsu HS; Wu YC
    J Gastrointest Surg; 2020 Jul; 24(7):1459-1468. PubMed ID: 31273552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic submucosal dissection versus surgery for T1b esophageal carcinoma: a single-center retrospective study.
    Zhang T; Wang H; Jin T; Wu Z; Li X; Zhang Q
    J Cancer Res Clin Oncol; 2024 May; 150(5):248. PubMed ID: 38724804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.